(±) 20-HDHA

CAT: 0804-HY-116663Size: 75 μg (290.28 μM x 750 μL in Ethanol)Dry Ice: NoHazardous: No
CAT#:0804-HY-116663Size:75 μg (290.28 μM x 750 μL in Ethanol)
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
(±) 20-HDHA ((±) 20-HDoHE) is a racemic mixture and is an autoxidation product of Docosahexaenoic acid (DHA) . (±) 20-HDHA is also formed by peroxidation process in human platelets and rat brain homogenate[1][2][3].
CAS Number
[90906-41-5]
Product Name Alternative
(±) 20-HDoHE
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/racemic-20-hdha.html
Concentration
290.28 μM * 750 μL in Ethanol
Purity
97.0
Solubility
10 mM in DMSO
Smiles
CCC(O)/C=C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O
Molecular Formula
C22H32O3
Molecular Weight
344.49
Precautions
H302, H315, H319, H335
References & Citations
[1]VanRollins M, et al. Autooxidation of docosahexaenoic acid: analysis of ten isomers of hydroxydocosahexaenoate. J Lipid Res. 1984 May;25 (5) :507-17.|[2]Kim HY, et al. Stereochemical analysis of hydroxylated docosahexaenoates produced by human platelets and rat brain homogenate. Prostaglandins. 1990 Nov;40 (5) :473-90.|[3]Hong S, et al. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J Am Soc Mass Spectrom. 2007 Jan;18 (1) :128-44.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Natural Products
Clinical Information
No Development Reported

Popular Products